{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:14:40Z","timestamp":1788527680324,"version":"build-2803163510"},"reference-count":28,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002066","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009342","name":"Aeras","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009342","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009342","name":"Aeras","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009342","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100021281","name":"Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"United Kingdom Department for International Development"},{"name":"Government of the Netherlands"},{"name":"International Cooperation, and Australian AID"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The efficacy and safety of the M72\/AS01E tuberculosis (TB) candidate vaccine were evaluated in the phase 2b randomized, placebo-controlled trial NCT01755598. In the trial, participants with Mycobacterium tuberculosis sensitization by a positive interferon-gamma release assay received either M72\/AS01E or placebo (randomized 1:1) and were followed for 3 years. In this descriptive study, we genetically characterized M. tuberculosis isolates from participants who developed pulmonary TB during the trial to assess variability among isolates and evaluate the possibility of preferential progression from infection to active TB by certain strains in M72\/AS01E and placebo recipients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>M. tuberculosis isolates were recovered from sputum samples and underwent DNA extraction and sequencing to assess lineage, antibiotic resistance profile, genetic variation, and genomic clusters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred isolates (37 M72\/AS01E, 63 placebo) were genetically characterized from 50 participants who developed microbiologically confirmed active pulmonary TB during the trial (20 M72\/AS01E, 30 placebo). Diverse M. tuberculosis lineages were identified in both M72\/AS01E and placebo recipients. No multidrug-resistant strains were detected. Genetic sequences corresponding to the antigenic components of M72\/AS01E showed low variation in pepA and high variation in PPE18. However, no apparent preferential distribution of variants was observed in M72\/AS01E or placebo recipients. Cluster analyses identified 10 genomic clusters with isolates from &amp;gt;1 participant, illustrating complex transmission dynamics and potential of coinfection by multiple strains within individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This descriptive analysis showed no apparent preferential distribution of local M. tuberculosis strains in M72\/AS01E or placebo recipients. These results support the continued development of this candidate vaccine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trials Registration<\/jats:title>\n                    <jats:p>The NCT01755598 study was registered at https:\/\/Cinicaltrials.gov on 19 December 2012. The trial protocol and statistical analysis plan can be accessed from the trial registration website https:\/\/clinicaltrials.gov\/study\/NCT01755598.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiag428","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:45:32Z","timestamp":1787921132000},"source":"Crossref","is-referenced-by-count":0,"title":["Genetic Characterization of\n                    <i>M. tuberculosis<\/i>\n                    Isolates From Participants in a Phase 2b Randomized Trial Evaluating the M72\/AS01E Tuberculosis Candidate Vaccine"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4737-5080","authenticated-orcid":false,"given":"Pierre","family":"Wattiau","sequence":"first","affiliation":[{"name":"Vaccine Clinical Laboratory and Assay Portfolio, GSK , Rixensart ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6983-1636","authenticated-orcid":false,"given":"Shaheed V","family":"Omar","sequence":"additional","affiliation":[{"name":"Centre for Tuberculosis, National Institute for Communicable Diseases , a Division of the National Health Laboratory Service, Johannesburg ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0734-7149","authenticated-orcid":false,"given":"Lavania","family":"Joseph","sequence":"additional","affiliation":[{"name":"Centre for Tuberculosis, National Institute for Communicable Diseases , a Division of the National Health Laboratory Service, Johannesburg ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4021-2300","authenticated-orcid":false,"given":"Marie-Ange","family":"Demoiti\u00e9","sequence":"additional","affiliation":[{"name":"Vaccine Clinical Laboratory and Assay Portfolio, GSK , Rixensart ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2650-3049","authenticated-orcid":false,"given":"M\u00e9lanie","family":"Gilbert","sequence":"additional","affiliation":[{"name":"R&D, VxCLAP, GSK , Wavre ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4108-2842","authenticated-orcid":false,"given":"Helen M","family":"Ayles","sequence":"additional","affiliation":[{"name":"Zambart , Lusaka ,","place":["Zambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8641-6792","authenticated-orcid":false,"given":"Andreas H","family":"Diacon","sequence":"additional","affiliation":[{"name":"TASK , Cape Town ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4299-2031","authenticated-orcid":false,"given":"Ann M","family":"Ginsberg","sequence":"additional","affiliation":[{"name":"Clinical Development, Aeras\/IAVI , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3491-1809","authenticated-orcid":false,"given":"Mark","family":"Hatherill","sequence":"additional","affiliation":[{"name":"South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease & Molecular Medicine and Department of Pathology, University of Cape Town , Cape Town ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[{"name":"Be Part Yoluntu Centre NPC , Paarl ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6872-5687","authenticated-orcid":false,"given":"James C","family":"Innes","sequence":"additional","affiliation":[{"name":"Aurum Klerksdorp CRS, The Aurum Institute , Klerksdorp ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1879-8471","authenticated-orcid":false,"given":"Mookho","family":"Malahleha","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Setshaba Research Centre , Pretoria ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0184-5705","authenticated-orcid":false,"given":"Neil","family":"Martinson","sequence":"additional","affiliation":[{"name":"Perinatal HIV Research Unit, University of the Witwatersrand , Soweto ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3609-5403","authenticated-orcid":false,"given":"Monde","family":"Muyoyeta","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Research in Zambia , Lusaka ,","place":["Zambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2266-8349","authenticated-orcid":false,"given":"Videlis","family":"Nduba","sequence":"additional","affiliation":[{"name":"Centre for Respiratory Diseases Research, Kenya Medical Research Institute , Nairobi ,","place":["Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8683-238X","authenticated-orcid":false,"given":"Dereck R","family":"Tait","sequence":"additional","affiliation":[{"name":"Clinical Development, Aeras\/IAVI , Cape Town ,","place":["South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2753-1800","authenticated-orcid":false,"given":"Robert J","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Wellcome Discovery Research Platforms in Infection, Centre for Infectious Diseases Research in Africa and Institute for Infectious Disease and Molecular Medicine, University of Cape Town , Cape Town ,","place":["South Africa"]},{"name":"Francis Crick Institute , London ,","place":["United Kingdom"]},{"name":"Department of Infectious Diseases, Imperial College London , London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6623-9522","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Roman","sequence":"additional","affiliation":[{"name":"Vaccine Clinical Sciences \u2013 Respiratory Vaccines, GSK , Wavre ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"2026090408261792900_jiag428-B1","volume-title":"Global tuberculosis report 2025 [Internet]","author":"World Health Organization (WHO)","year":"2025"},{"key":"2026090408261792900_jiag428-B2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.5588\/ijtld.17.0835","article-title":"Global tuberculosis targets and milestones set for 2016-2035: definition and rationale","volume":"22","author":"Floyd","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026090408261792900_jiag428-B3","first-page":"73","article-title":"BCG vaccines: WHO position paper \u2013 February 2018","volume":"93","author":"World Health Organization (WHO)","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"2026090408261792900_jiag428-B4","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/vaccines11081304","article-title":"Next-generation TB vaccines: progress, challenges, and prospects","volume":"11","author":"Zhuang","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"2026090408261792900_jiag428-B5","volume-title":"TB vaccine clinical pipeline","author":"Stop TB Partnership","year":"2025"},{"key":"2026090408261792900_jiag428-B6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12865-015-0119-7","article-title":"Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens","volume":"16","author":"Mortier","year":"2015","journal-title":"BMC Immunol"},{"key":"2026090408261792900_jiag428-B7","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein","volume":"172","author":"Skeiky","year":"2004","journal-title":"J Immunol"},{"key":"2026090408261792900_jiag428-B8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/hv.8570","article-title":"The candidate tuberculosis vaccine Mtb72F\/AS02A: tolerability and immunogenicity in humans","volume":"5","author":"Von Eschen","year":"2009","journal-title":"Hum Vaccin"},{"key":"2026090408261792900_jiag428-B9","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1128\/IAI.00335-07","article-title":"DNA polymorphisms in the pepA and PPE18 genes among clinical strains of Mycobacterium tuberculosis: implications for vaccine efficacy","volume":"75","author":"Hebert","year":"2007","journal-title":"Infect Immun"},{"key":"2026090408261792900_jiag428-B10","doi-asserted-by":"crossref","first-page":"e0152200","DOI":"10.1371\/journal.pone.0152200","article-title":"High sequence variability of the ppE18 gene of clinical Mycobacterium tuberculosis complex strains potentially impacts effectivity of vaccine candidate M72\/AS01E","volume":"11","author":"Homolka","year":"2016","journal-title":"PLoS One"},{"key":"2026090408261792900_jiag428-B11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"2026090408261792900_jiag428-B12","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N Engl J Med"},{"key":"2026090408261792900_jiag428-B13","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N Engl J Med"},{"key":"2026090408261792900_jiag428-B14","doi-asserted-by":"crossref","first-page":"601737","DOI":"10.1155\/2013\/601737","article-title":"Interferon-gamma release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: an overview of the evidence","volume":"2013","author":"Trajman","year":"2013","journal-title":"Pulm Med"},{"key":"2026090408261792900_jiag428-B15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/molbev\/msu300","article-title":"IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies","volume":"32","author":"Nguyen","year":"2015","journal-title":"Mol Biol Evol"},{"key":"2026090408261792900_jiag428-B16","doi-asserted-by":"crossref","first-page":"W256","DOI":"10.1093\/nar\/gkz239","article-title":"Interactive Tree Of Life (iTOL) v4: recent updates and new developments","volume":"47","author":"Letunic","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2026090408261792900_jiag428-B17","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1038\/ncomms5812","article-title":"A robust SNP barcode for typing Mycobacterium tuberculosis complex strains","volume":"5","author":"Coll","year":"2014","journal-title":"Nat Commun"},{"key":"2026090408261792900_jiag428-B18","volume-title":"Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance","author":"World Health Organization (WHO)","year":"2021"},{"key":"2026090408261792900_jiag428-B19","doi-asserted-by":"crossref","first-page":"e2017831118","DOI":"10.1073\/pnas.2017831118","article-title":"Local adaptation of Mycobacterium tuberculosis on the Tibetan Plateau","volume":"118","author":"Liu","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026090408261792900_jiag428-B20","doi-asserted-by":"crossref","first-page":"e61805","DOI":"10.7554\/eLife.61805","article-title":"In-host population dynamics of Mycobacterium tuberculosis complex during active disease","volume":"10","author":"Vargas","year":"2021","journal-title":"eLife"},{"key":"2026090408261792900_jiag428-B21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ebiom.2018.07.030","article-title":"Harmonized genome wide typing of tubercle bacilli using a web-based gene-by-gene nomenclature system","volume":"34","author":"Kohl","year":"2018","journal-title":"EBioMedicine"},{"key":"2026090408261792900_jiag428-B22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1473-3099(12)70277-3","article-title":"Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study","volume":"13","author":"Walker","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2026090408261792900_jiag428-B23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.smim.2014.09.012","article-title":"Consequences of genomic diversity in Mycobacterium tuberculosis","volume":"26","author":"Coscolla","year":"2014","journal-title":"Semin Immunol"},{"key":"2026090408261792900_jiag428-B24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1473-3099(18)30222-6","article-title":"Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey","volume":"18","author":"Ismail","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2026090408261792900_jiag428-B25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4103\/ijmy.ijmy_70_25","article-title":"PPE18 and PepA variations in Mycobacterium tuberculosis clinical isolates from Makassar, Indonesia: challenges for immune recognition and vaccine development","volume":"14","author":"Theorupun","year":"2025","journal-title":"Int J Mycobacteriol"},{"key":"2026090408261792900_jiag428-B26","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ijid.2023.04.001","article-title":"Genomic and geospatial epidemiology of Mycobacterium tuberculosis in Oman: first national insight using whole genome sequencing","volume":"130 Suppl 1","author":"Al-Jardani","year":"2023","journal-title":"Int J Infect Dis"},{"key":"2026090408261792900_jiag428-B27","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1128\/CMR.00021-12","article-title":"Mixed-strain Mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control","volume":"25","author":"Cohen","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"2026090408261792900_jiag428-B28","doi-asserted-by":"crossref","first-page":"595312","DOI":"10.3389\/fmicb.2020.595312","article-title":"Predicted structural variability of Mycobacterium tuberculosis PPE18 protein with immunological implications among clinical strains","volume":"11","author":"Hakim","year":"2020","journal-title":"Front Microbiol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiag428\/70827893\/jiag428.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiag428\/70827893\/jiag428.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:26:27Z","timestamp":1788524787000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/advance-article\/doi\/10.1093\/infdis\/jiag428\/8772314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":28,"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiag428","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"article-number":"jiag428"}}